---
trial_id: 1719
discovery_date: 2022-08-06 21:51:43.979738
date: 2022-08-06 21:51:43.979738
title: "A Double Blind, Randomised, Placebo Controlled Study Investigating Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis in patients treated with Copaxone..."
summary: |
  <p>EudraCT Number: 2006-001827-21<br />Sponsor Protocol Number: CoSim-01<br />Sponsor Name: Glostrup Hospital, Dep. of Neurology<br />Start Date: 2009-03-06<br />Medical condition: Multiple Sclerosis<br />Disease: <br />Version: 9.1<br />SOC Term: <br />Classification Code: 10028245<br />Term: Multiple sclerosis<br />Level: LLT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-001827-21/DK">DK</a> (Prematurely Ended)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-001827-21'
published_date: NaT
trial_source: 
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2006-001827-21<br />Sponsor Protocol Number: CoSim-01<br />Sponsor Name: Glostrup Hospital, Dep. of Neurology<br />Start Date: 2009-03-06<br />Medical condition: Multiple Sclerosis<br />Disease: <br />Version: 9.1<br />SOC Term: <br />Classification Code: 10028245<br />Term: Multiple sclerosis<br />Level: LLT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-001827-21/DK">DK</a> (Prematurely Ended)</p>